Financials

News Discussions Technicals Seasonals

NSB fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. It's research and development program is focused on developing a treatment for stroke-related brain injury and dementia or Alzheimer's disease, and a diagnostic for early-stage Alzheimer's disease. The company was founded by William Harold Clough on November 14, 2002 and is headquartered in Nedlands, Australia.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

NSB does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company